Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Angelica sinensis root—commonly known as Dong Quai—is a traditional herbal remedy derived from the root of the Angelica sinensis plant. It has been used for over a thousand years in Chinese medicine and other East Asian medical systems primarily to address female health concerns such as menstrual disorders and menopausal symptoms. The main bioactive compound is ligustilide. Pharmacologically, it is thought to possess anti-inflammatory, antispasmodic, anticoagulant, and analgesic properties. Some studies suggest potential effects on hormonal balance and blood circulation; however clinical evidence supporting these uses remains limited. Angelica sinensis root is not an approved pharmaceutical drug but is widely available as a dietary supplement or ingredient in over-the-counter products[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Angelica sinensis root.